ELECTRONIC INFORMED CONSENT MODEL DEVELOPMENT FOR IMPLEMENTATION IN CLINICAL TRIALS IN UKRAINE


Dobrova Vy, Zupanets KО, Kolodyezna Ty, Yuriytimchenko Timchenko

Abstract


Objectives: The process of signing the informed consent (IC) is one of the essential procedures during organizing and conducting the clinical trial (CT) of any new drug. During this procedure, the volunteers should read the IC form that is often difficult to understand. Analysis of literature showed lack of experience in use of electronic systems in the IC signing in Ukraine. Abroad such systems are quite new. Thus, the aim of this work is the rationale for the introduction of electronic IC to CT drugs in Ukraine and the development of its general model.

Methods: Experience in the use of electronic systems in IC signing analysis was carried out using methods of system analysis, synthesis, abstraction, and generalization.

Results: Thus, during the signing process of paper forms risks and errors may arise such as loss of paper copies and signing of an incorrect version of the document by the volunteer. With the use of electronic forms, it is possible to prevent three categories of risks in preparation and signing, such as risks in the development, use, and auditing of IC forms. The opportunities of the electronic IC system to protect trial subjects in its use during organizing and conducting of CT were showed.

Conclusions: The study showed that such systems are effective. Therefore, it seems appropriate to introduce electronic IC in CT of new drugs in Ukraine. We have formulated requirements to the system and determined its structure for optimal use.


Keywords


Clinical trials, Electronic informed consent, Clinical trial quality management, Risk management.

| PDF |

References


International Conference оn Harmonisation оf Technical Requirements for Registration оf Pharmaceuticals for Human Use. Guideline for Good Clinical Practice. ICH Harmonised Guideline Integrated Addendum to ICH E6 (R1). In: Guideline for Good Clinical Practice E6(R2); 2015. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R2__Addendum_Step2.pdf.

Zupanets KO, Dobrova VY, Kolodeznaya TY, Ratushnaya KL. The analysis of compliance with bioethical norms of signing the informed consent in organizing trials of drugs. J Chem Pharm Res 2015;7(11):756-62.

Zupanets KO, Dobrova VY, Kolodeznaya TY. Study of the trial subjects protection aspects in Phase I clinical trials and bioequivalence studies. Zaporozhye Med J 2016;2(95):93-7.

Litwin J Engagement Shift: Informed Consent in the Digital Era. Applied Clinical Trials Available from: http://www.appliedclinicaltrialsonline.com/engagement-shift-informed-consent-digital-era? pageID=4.

Use of Electronic Informed Consent: FDA Guidance. Available from: https://www.fda.gov/downloads/drugs/guidances/ucm436811.pdf.

Onapproval of Clinical trials and Expertise of Clinical Trials and Model Regulations of the Ethics Committee: Order of Ministry of Health of Ukraine №. 690 From 23.09.2009 (A Sam ended by №. 523 From 12.07.2012, № 304 від 06.05.2014, № 966 From 18.12.2014) Available from: http://www.zakon.rada.gov.ua/cgi–bin/laws/main. cgi?nreg=z1010–09. 7. Pei LL, Umar II. The application of communication technology in hospital and community pharmacies: A brief review. Int J Pharm Pharm Sci 2015;7(3):1-5.

Umashankar V, Gurunathan S. Drug discovery: An appraisal. Int J Pharm Pharm Sci 2015;7(4):59-66.

The Essential Guide to Electronic Informed Consent. Available from: http://www.resources.crfhealth.com/ebooks/the-essential-guide-to-electronic-informed-consent-2.




About this article

Title

ELECTRONIC INFORMED CONSENT MODEL DEVELOPMENT FOR IMPLEMENTATION IN CLINICAL TRIALS IN UKRAINE

Topics

Clinical Pharmacology

Keywords

Clinical trials, Electronic informed consent, Clinical trial quality management, Risk management.

DOI

10.22159/ajpcr.2017.v10i12.21044

Date

01-12-2017

Additional Links

Manuscript Submission

Journal

Asian Journal of Pharmaceutical and Clinical Research
Vol 10 Issue 12 December 2017 Page: 238-241

Print ISSN

0974-2441

Online ISSN

2455-3891

Statistics

16 Views | 44 Downloads

Authors & Affiliations

Dobrova Vy
Department of Clinical Pharmacology and Clinical Pharmacy, National University of Pharmacy, Kharkiv, Ukraine.
Ukraine

Zupanets KО
Department of Clinical Pharmacology and Clinical Pharmacy, National University of Pharmacy, Kharkiv, Ukraine.
Ukraine

Kolodyezna Ty
Department of Clinical Pharmacology and Clinical Pharmacy, National University of Pharmacy, Kharkiv, Ukraine.
Ukraine

Yuriytimchenko Timchenko
Department of Clinical Pharmacology and Clinical Pharmacy, National University of Pharmacy, Kharkiv, Ukraine.
Ukraine


Article Tools


Email this article (Login required)
Email the author (Login required)

Refbacks

  • There are currently no refbacks.